Oncogene - Table of Contents alert Volume 33 Issue 32

If you are unable to see the message below, click here to view.

Advertisement CRISPR/Cas9 monoclonal antibody now available A breakthrough in genome engineering   Diagenode now offers the first monoclonal antibody against CRISPR/Cas9 on the market. Better performance that tag antibodies Validated for all major applications such as immunoblot, immunoprecipitation, and IF Recognizes both Cas9 and dCas9 Learn more  TABLE OF CONTENTS Volume 33, Issue 32 (August 2014) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement EXCLUSIVE DEALS: Lab equipment and services Learn more and save on the latest lab equipment you need! Before you buy, VISIT MARKETPLACE    Review Top The B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignancies K H Shain and J Tao Oncogene 2014 33: 4107-4113; advance online publication, September 16, 2013; 10.1038/onc.2013.379 Abstract | Full Text Original Articles Top A phosphatase-independent gain-of-function mutation in PTEN triggers aberrant cell growth in astrocytes through an autocrine IGF-1 loop S Fernández, L Genis and I Torres-Alemán Oncogene 2014 33: 4114-4122; advance online publication, September 23, 2013; 10.1038/onc.2013.376 Abstract | Full Text Helicobacter pylori generates cells with cancer stem cell properties via epithelial–mesenchymal transition-like changes E Bessède, C Staedel, L A Acuña Amador, P H Nguyen, L Chambonnier, M Hatakeyama, G Belleannée, F Mégraud and C Varon Oncogene 2014 33: 4123-4131; advance online publication, October 7, 2013; 10.1038/onc.2013.380 Abstract | Full Text PTEN ablation in RasHa/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition F H Macdonald, D Yao, J A Quinn and D A Greenhalgh Oncogene 2014 33: 4132-4143; advance online publication, September 16, 2013; 10.1038/onc.2013.372 Abstract | Full Text FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance OPEN P Khongkow, U Karunarathna, M Khongkow, C Gong, A R Gomes, E Yagüe, L J Monteiro, M Kongsema, S Zona, E P S Man, J W-H Tsang, R C Coombes, K-J Wu, U-S Khoo, R H Medema, R Freire and E W-F Lam Oncogene 2014 33: 4144-4155; advance online publication, October 21, 2013; 10.1038/onc.2013.457 Abstract | Full Text EIF3i promotes colon oncogenesis by regulating COX-2 protein synthesis and β-catenin activation J Qi, Z Dong, J Liu and J-T Zhang Oncogene 2014 33: 4156-4163; advance online publication, September 23, 2013; 10.1038/onc.2013.397 Abstract | Full Text E2F1 drives chemotherapeutic drug resistance via ABCG2 OPEN M T Rosenfeldt, L A Bell, J S Long, J O'Prey, C Nixon, F Roberts, C Dufès and K M Ryan Oncogene 2014 33: 4164-4172; advance online publication, November 25, 2013; 10.1038/onc.2013.470 Abstract | Full Text The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx) OPEN R Ciarapica, M De Salvo, E Carcarino, G Bracaglia, L Adesso, P P Leoncini, A Dall'Agnese, Z S Walters, F Verginelli, L De Sio, R Boldrini, A Inserra, G Bisogno, A Rosolen, R Alaggio, A Ferrari, P Collini, M Locatelli, S Stifani, I Screpanti, S Rutella, Q Yu, V E Marquez, J Shipley, S Valente, A Mai, L Miele, P L Puri, F Locatelli, D Palacios and R Rota Oncogene 2014 33: 4173-4184; advance online publication, November 11, 2013; 10.1038/onc.2013.471 Abstract | Full Text Short Communication Top The receptor tyrosine kinase Axl regulates cell–cell adhesion and stemness in cutaneous squamous cell carcinoma M A Cichoń, Z Szentpetery, M P Caley, E S Papadakis, I C Mackenzie, C H Brennan and E A O'Toole Oncogene 2014 33: 4185-4192; advance online publication, September 23, 2013; 10.1038/onc.2013.388 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.